Metabolism
Growth Retardation, Impaired Triacylglycerol Catabolism, Hepatic Steatosis, and Lethal Skin Barrier Defect in Mice Lacking Comparative Gene Identification-58 (CGI-58)*

https://doi.org/10.1074/jbc.M109.081877Get rights and content
Under a Creative Commons license
open access

Comparative gene identification-58 (CGI-58), also designated as α/β-hydrolase domain containing-5 (ABHD-5), is a lipid droplet-associated protein that activates adipose triglyceride lipase (ATGL) and acylates lysophosphatidic acid. Activation of ATGL initiates the hydrolytic catabolism of cellular triacylglycerol (TG) stores to glycerol and nonesterified fatty acids. Mutations in both ATGL and CGI-58 cause “neutral lipid storage disease” characterized by massive accumulation of TG in various tissues. The analysis of CGI-58-deficient (Cgi-58−/−) mice, presented in this study, reveals a dual function of CGI-58 in lipid metabolism. First, systemic TG accumulation and severe hepatic steatosis in newborn Cgi-58−/− mice establish a limiting role for CGI-58 in ATGL-mediated TG hydrolysis and supply of nonesterified fatty acids as energy substrate. Second, a severe skin permeability barrier defect uncovers an essential ATGL-independent role of CGI-58 in skin lipid metabolism. The neonatal lethal skin barrier defect is linked to an impaired hydrolysis of epidermal TG. As a consequence, sequestration of fatty acids in TG prevents the synthesis of acylceramides, which are essential lipid precursors for the formation of a functional skin permeability barrier. This mechanism may also underlie the pathogenesis of ichthyosis in neutral lipid storage disease patients lacking functional CGI-58.

Gene Knockout
Lipase
Lipolysis
Liver
Skin
ATGL
CGI-58/ABHD5
Neutral Lipid Storage Disease
Skin Barrier
Triacylglycerol Metabolism

Cited by (0)

*

This work was supported by Grant “GOLD-Genomics of Lipid-associated Disorders” (which is part of the Austrian Genome Project “GEN-AU Genome Research in Austria”) funded by the Austrian Ministry for Science and Research and by Grant SFB LIPOTOX F30-B05 and FWF Project P20602-B05 funded by the Austrian Fonds zur Förderung der Wissenschaftlichen Forschung.

The on-line version of this article (available at http://www.jbc.org) contains supplemental Figs. S1 and S2.